Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-State, Tribal, Local and Territorial (STLT) Subcommittee, 8661-8662 [2015-03252]

Download as PDF Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices 8661 DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—State, Tribal, Local and Territorial (STLT) Subcommittee The meeting announced below concerns Public Health Research on Modifiable Risk Factors for Spina Bifida, DD15–001, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 10:00 a.m.–6:00 p.m., March 19, 2015 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Public Health Research on Modifiable Risk Factors for Spina Bifida, DD15– 001, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The meeting announced below concerns Comparison and Validation of Screening Tools for Substance Use Among Pregnant Women, DP15–003, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: emcdonald on DSK67QTVN1PROD with NOTICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–03254 Filed 2–17–15; 8:45 am] BILLING CODE 4163–18–P Time and Date 9:00 a.m.–6:30 p.m., March 18, 2015 (Closed) Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Comparison and Validation of Screening Tools for Substance Use among Pregnant Women, DP15–003, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–03255 Filed 2–17–15; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 19:32 Feb 17, 2015 Jkt 235001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 3:30 p.m.—5:00 p.m. EDT, March 13, 2015. Place: This meeting will be held by teleconference. Status: This meeting is open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment, which is tentatively scheduled from 4:45 p.m. to 4:55 p.m. To participate on the teleconference, please dial (888) 233–0592 and enter code 33288611. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategies and future needs and challenges faced by State, Tribal, Local and Territorial health agencies, and will provide guidance on opportunities for CDC. Matters for Discussion: The STLT Subcommittee members will discuss progress on implementation of ACDadopted recommendations related to Public Health Surveillance, Public Health Finance and Social Determinants of Health as they relate to STLT public health agencies. The agenda is subject to change as priorities dictate. Contact Person for More Information: Judith Monroe, M.D., Designated Federal Officer, State, Tribal, Local and Territorial Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S E–70, Atlanta, Georgia 30333, Telephone (404) 498– 0300, Email: OSTLTSDirector@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and E:\FR\FM\18FEN1.SGM 18FEN1 8662 Federal Register / Vol. 80, No. 32 / Wednesday, February 18, 2015 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2015–03252 Filed 2–17–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Establishing a Vision and Eye Health Surveillance System for the Nation, DP15–004, initial review. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 10:00 a.m.–5:00 p.m., March 10, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Establishing a Vision and Eye Health Surveillance System for the Nation, DP15–004, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F–80, Atlanta, Georgia 30341, Telephone: (770) 488– 3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–03256 Filed 2–17–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families OMB No.: OMB No: 0970–265. Description: The Department of Health and Human Services (HHS), Administration for Children and Families (ACF) proposes to revise the ANA Reviewer Profile for Panel Review Participation Form. The ANA Reviewer Profile for Panel Review Participation Form is used to collect information from prospective proposal reviewers in compliance with 42 U.S.C. 2991d 1. First time reviewers will be required to complete all sections of the form while returning reviewers will be required to complete the first section of the document and other necessary updates. The form allows the Commissioner of ANA to select qualified people to review grant applications submitted in response to funding opportunity announcements for ANA’s primary programs: Social and Economic Development Strategies (SEDS); Native Language Preservation and Maintenance; and Environmental Regulatory Enhancement. The panel review process is a legislative mandate in the ANA grant funding process. Respondents: All US citizens including: Native Americans, Native Alaskans, Native Hawaiians and other Pacific Islanders. Proposed Information Collection Activity: Comment Request Title: ANA Reviewer Profile for Panel Review Participation Form. ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours ANA Consultant and Evaluator Qualifications Form ....................................... emcdonald on DSK67QTVN1PROD with NOTICES Instrument 300 1 .5 150 Estimated Total Annual Burden Hours: 150. In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email address: infocollection@ acf.hhs.gov. All requests should be VerDate Sep<11>2014 20:47 Feb 17, 2015 Jkt 235001 identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to PO 00000 Frm 00074 Fmt 4703 Sfmt 9990 comments and suggestions submitted within 60 days of this publication. Robert Sargis, Report Clearance Officer. [FR Doc. 2015–03302 Filed 2–17–15; 8:45 am] BILLING CODE 4184–01–P E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 80, Number 32 (Wednesday, February 18, 2015)]
[Notices]
[Pages 8661-8662]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03252]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention--State, Tribal, Local and Territorial (STLT) 
Subcommittee

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
subcommittee:
    Time and Date: 3:30 p.m.--5:00 p.m. EDT, March 13, 2015.
    Place: This meeting will be held by teleconference.
    Status: This meeting is open to the public, limited only by the 
availability of telephone ports. The public is welcome to participate 
during the public comment, which is tentatively scheduled from 4:45 
p.m. to 4:55 p.m. To participate on the teleconference, please dial 
(888) 233-0592 and enter code 33288611.
    Purpose: The Subcommittee will provide advice to the CDC Director 
through the ACD on strategies and future needs and challenges faced by 
State, Tribal, Local and Territorial health agencies, and will provide 
guidance on opportunities for CDC.
    Matters for Discussion: The STLT Subcommittee members will discuss 
progress on implementation of ACD-adopted recommendations related to 
Public Health Surveillance, Public Health Finance and Social 
Determinants of Health as they relate to STLT public health agencies.
    The agenda is subject to change as priorities dictate.
    Contact Person for More Information: Judith Monroe, M.D., 
Designated Federal Officer, State, Tribal, Local and Territorial 
Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton 
Road NE., M/S E-70, Atlanta, Georgia 30333, Telephone (404) 498-0300, 
Email: OSTLTSDirector@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 8662]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2015-03252 Filed 2-17-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.